| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.994 | 0.001 | 0.994 | Androgen antagonist | 0.937 0.002 DBMET02845 0.948 0.002 DBMET02846 | ||
| 0.991 | 0.003 | 0.991 | Antiinflammatory | 0.982 0.004 DBMET02845 0.99 0.003 DBMET02846 | ||
| 0.982 | 0.002 | 0.982 | Hypoxia-inducible factor 1 alpha inhibitor | 0.866 0.003 DBMET02845 0.919 0.002 DBMET02846 | ||
| 0.977 | 0.001 | 0.977 | Androgen agonist | 0.969 0.001 DBMET02845 0.876 0.001 DBMET02846 | ||
| 0.961 | 0.004 | 0.961 | Toll-Like receptor agonist | 0.955 0.004 DBMET02845 0.958 0.004 DBMET02846 | ||
| 0.961 | 0.004 | 0.961 | Toll-Like receptor 7 agonist | 0.954 0.004 DBMET02845 0.957 0.004 DBMET02846 | ||
| 0.94 | 0.001 | 0.94 | Glucocorticoid antagonist | 0.757 0.001 DBMET02845 0.879 0.001 DBMET02846 | ||
| 0.937 | 0 | 0.937 | Transcortin receptor antagonist | 0.607 0 DBMET02845 0.888 0 DBMET02846 | ||
| 0.904 | 0.002 | 0.904 | Antipruritic | 0.683 0.003 DBMET02845 0.804 0.002 DBMET02846 | ||
| 0.904 | 0.006 | 0.904 | Transcription factor NF kappa B inhibitor | 0.8 0.013 DBMET02845 0.894 0.006 DBMET02846 | ||
| 0.868 | 0 | 0.868 | Glucocorticoid agonist | 0.762 0.001 DBMET02845 0.834 0 DBMET02846 | ||
| 0.826 | 0.001 | 0.826 | Progesterone antagonist | 0.615 0.002 DBMET02845 0.758 0.001 DBMET02846 | ||
| 0.796 | 0.004 | 0.798 | Immunosuppressant | 0.798 0.004 DBMET02845 0.79 0.004 DBMET02846 | DBMET02845 | |
| 0.768 | 0 | 0.768 | Corticosteroid-like | 0.49 0 DBMET02845 0.663 0 DBMET02846 | ||
| 0.7 | 0.003 | 0.7 | NOS3 expression enhancer | 0.611 0.004 DBMET02845 0.661 0.004 DBMET02846 | ||
| 0.68 | 0.001 | 0.68 | Interferon gamma antagonist | 0.619 0.002 DBMET02845 0.632 0.002 DBMET02846 | ||
| 0.667 | 0.001 | 0.667 | Aldosterone antagonist | 0.48 0.002 DBMET02845 0.472 0.002 DBMET02846 | ||
| 0.616 | 0.004 | 0.616 | Interleukin 4 antagonist | 0.477 0.004 DBMET02845 0.537 0.004 DBMET02846 | ||
| 0.612 | 0.003 | 0.648 | Aromatase inhibitor | 0.271 0.006 DBMET02845 0.648 0.002 DBMET02846 | DBMET02846 | |
| 0.605 | 0 | 0.605 | Arachidonic acid antagonist | 0.402 0 DBMET02845 0.486 0 DBMET02846 | ||
| 0.606 | 0.002 | 0.606 | Lipocortins synthesis antagonist | 0.595 0.002 DBMET02845 0.58 0.002 DBMET02846 | ||
| 0.576 | 0 | 0.576 | Lipocortins synthesis agonist | 0.372 0 DBMET02845 0.51 0 DBMET02846 | ||
| 0.574 | 0.005 | 0.596 | Diuretic | 0.596 0.005 DBMET02845 0.459 0.01 DBMET02846 | DBMET02845 | |
| 0.568 | 0.001 | 0.758 | Anabolic | 0.758 0.001 DBMET02845 0.37 0.001 DBMET02846 | DBMET02845 | |
| 0.552 | 0.005 | 0.605 | P-glycoprotein inhibitor | 0.306 0.028 DBMET02845 0.605 0.005 DBMET02846 | DBMET02846 | |
| 0.588 | 0.052 | 0.588 | Apoptosis agonist | 0.499 0.075 DBMET02845 0.558 0.058 DBMET02846 | ||
| 0.55 | 0.025 | 0.577 | Cholesterol antagonist | 0.577 0.022 DBMET02845 0.43 0.044 DBMET02846 | DBMET02845 | |
| 0.514 | 0.007 | 0.514 | Anesthetic general | 0.396 0.017 DBMET02845 0.419 0.014 DBMET02846 | ||
| 0.469 | 0.003 | 0.469 | Mineralocorticoid receptor antagonist | 0.352 0.003 DBMET02845 0.402 0.003 DBMET02846 | ||
| 0.445 | 0.008 | 0.46 | Sodium/bile acid cotransporter inhibitor | 0.446 0.008 DBMET02845 0.46 0.006 DBMET02846 | DBMET02846 | |
| 0.452 | 0.02 | 0.5 | Nitric oxide antagonist | 0.416 0.024 DBMET02845 0.5 0.016 DBMET02846 | DBMET02846 | |
| 0.395 | 0.004 | 0.395 | Interleukin 5 antagonist | 0.297 0.004 DBMET02845 0.327 0.004 DBMET02846 | ||
| 0.382 | 0.005 | 0.382 | Estrogen antagonist | 0.282 0.007 DBMET02845 0.327 0.005 DBMET02846 | ||
| 0.413 | 0.046 | 0.413 | Immunostimulant | 0.368 0.059 DBMET02845 0.357 0.062 DBMET02846 | ||
| 0.391 | 0.032 | 0.391 | Interleukin antagonist | 0.208 0.079 DBMET02845 0.327 0.042 DBMET02846 | ||
| 0.368 | 0.009 | 0.374 | Interleukin 6 antagonist | 0.178 0.056 DBMET02845 0.374 0.009 DBMET02846 | DBMET02846 | |
| 0.371 | 0.026 | 0.371 | DNA synthesis inhibitor | 0.277 0.052 DBMET02845 0.32 0.037 DBMET02846 | ||
| 0.354 | 0.045 | 0.462 | Antioxidant | 0.462 0.025 DBMET02845 0.346 0.047 DBMET02846 | DBMET02845 | |
| 0.309 | 0.002 | 0.309 | Progesterone agonist | 0.21 0.002 DBMET02845 0.277 0.002 DBMET02846 | ||
| 0.355 | 0.054 | 0.355 | Aldehyde oxidase inhibitor | 0.284 0.071 DBMET02845 0.215 0.097 DBMET02846 | ||
| 0.305 | 0.017 | 0.305 | Tumour necrosis factor antagonist | 0.204 0.051 DBMET02846 | ||
| 0.356 | 0.069 | 0.356 | Angiogenesis inhibitor | 0.205 0.164 DBMET02845 0.305 0.09 DBMET02846 | ||
| 0.334 | 0.065 | 0.343 | Immunomodulator | 0.271 0.099 DBMET02845 0.343 0.062 DBMET02846 | DBMET02846 | |
| 0.325 | 0.058 | 0.359 | Interleukin 2 agonist | 0.359 0.042 DBMET02845 0.259 0.109 DBMET02846 | DBMET02845 | |
| 0.289 | 0.027 | 0.289 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.177 0.097 DBMET02845 0.209 0.065 DBMET02846 | ||
| 0.251 | 0.01 | 0.251 | Topoisomerase II alpha inhibitor | 0.211 0.013 DBMET02846 | ||
| 0.236 | 0.007 | 0.236 | Estrogen agonist | 0.227 0.007 DBMET02845 0.192 0.008 DBMET02846 | ||
| 0.229 | 0.003 | 0.229 | RNA-directed RNA polymerase stimulant | 0.22 0.003 DBMET02845 0.169 0.004 DBMET02846 | ||
| 0.255 | 0.028 | 0.278 | Melanin inhibitor | 0.278 0.025 DBMET02845 0.167 0.062 DBMET02846 | DBMET02845 | |
| 0.242 | 0.019 | 0.331 | Cholesterol synthesis inhibitor | 0.331 0.008 DBMET02845 0.182 0.032 DBMET02846 | DBMET02845 | |
| 0.236 | 0.027 | 0.236 | Topoisomerase II inhibitor | 0.198 0.034 DBMET02846 | ||
| 0.351 | 0.145 | 0.351 | Caspase 9 stimulant | 0.338 0.156 DBMET02845 0.347 0.148 DBMET02846 | ||
| 0.213 | 0.007 | 0.213 | Inducible nitric-oxide synthase inhibitor | 0.075 0.072 DBMET02845 0.184 0.01 DBMET02846 | ||
| 0.2 | 0.007 | 0.2 | T cell inhibitor | 0.126 0.013 DBMET02845 0.155 0.009 DBMET02846 | ||
| 0.191 | 0.005 | 0.191 | 5-Alpha-reductase inhibitor | 0.185 0.005 DBMET02845 0.106 0.009 DBMET02846 | ||
| 0.226 | 0.051 | 0.249 | Hepatoprotectant | 0.226 0.052 DBMET02845 0.249 0.043 DBMET02846 | DBMET02846 | |
| 0.211 | 0.037 | 0.289 | Lipid peroxidase inhibitor | 0.289 0.02 DBMET02845 0.161 0.061 DBMET02846 | DBMET02845 | |
| 0.314 | 0.15 | 0.314 | Cyclophilin D inhibitor | 0.291 0.171 DBMET02845 0.255 0.207 DBMET02846 | ||
| 0.175 | 0.026 | 0.201 | Antineoplastic antibiotic | 0.163 0.028 DBMET02845 0.201 0.021 DBMET02846 | DBMET02846 | |
| 0.156 | 0.011 | 0.156 | Estrogen receptor alpha antagonist | 0.143 0.013 DBMET02845 0.127 0.016 DBMET02846 | ||
| 0.211 | 0.066 | 0.211 | Neurotrophic factor enhancer | 0.195 0.082 DBMET02845 0.205 0.072 DBMET02846 | ||
| 0.147 | 0.005 | 0.147 | Estrogen receptor alpha agonist | 0.144 0.005 DBMET02845 0.102 0.008 DBMET02846 | ||
| 0.223 | 0.083 | 0.223 | Angiogenesis stimulant | 0.206 0.092 DBMET02845 0.189 0.1 DBMET02846 | ||
| 0.17 | 0.035 | 0.17 | DNA intercalator | 0.132 0.051 DBMET02846 | ||
| 0.142 | 0.008 | 0.142 | Estrogen receptor beta agonist | 0.139 0.008 DBMET02845 0.097 0.012 DBMET02846 | ||
| 0.165 | 0.039 | 0.165 | Farnesoid X receptor antagonist | 0.158 0.044 DBMET02845 0.156 0.046 DBMET02846 | ||
| 0.156 | 0.031 | 0.156 | Interleukin 8 antagonist | |||
| 0.141 | 0.018 | 0.141 | Estrogen receptor beta antagonist | 0.127 0.026 DBMET02845 0.128 0.025 DBMET02846 | ||
| 0.25 | 0.128 | 0.321 | Apoptosis antagonist | 0.26 0.118 DBMET02845 0.321 0.072 DBMET02846 | DBMET02846 | |
| 0.133 | 0.011 | 0.137 | Na+ K+ transporting ATPase inhibitor | 0.137 0.009 DBMET02845 0.125 0.014 DBMET02846 | DBMET02845 | |
| 0.159 | 0.038 | 0.177 | Pregnane X receptor agonist | 0.177 0.021 DBMET02845 0.158 0.04 DBMET02846 | DBMET02845 | |
| 0.122 | 0.002 | 0.122 | Glucose-6-phosphate dehydrogenase inhibitor | 0.063 0.006 DBMET02845 0.122 0.002 DBMET02846 | ||
| 0.162 | 0.043 | 0.162 | DNA polymerase I inhibitor | 0.161 0.043 DBMET02845 0.142 0.054 DBMET02846 | ||
| 0.122 | 0.004 | 0.122 | Nitric oxide donor | 0.105 0.007 DBMET02845 0.118 0.004 DBMET02846 | ||
| 0.142 | 0.026 | 0.191 | Toll-Like receptor 4 antagonist | 0.191 0.008 DBMET02845 0.134 0.032 DBMET02846 | DBMET02845 | |
| 0.151 | 0.041 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.13 0.12 DBMET02845 0.146 0.053 DBMET02846 | ||
| 0.157 | 0.057 | 0.157 | Cytokine production inhibitor | 0.112 0.098 DBMET02845 | ||
| 0.197 | 0.112 | 0.253 | Tumour necrosis factor alpha release inhibitor | 0.253 0.073 DBMET02845 0.158 0.148 DBMET02846 | DBMET02845 | |
| 0.157 | 0.077 | 0.157 | Thrombolytic | 0.157 0.077 DBMET02845 0.119 0.112 DBMET02846 | ||
| 0.077 | 0.005 | 0.077 | Estrone sulfatase inhibitor | 0.06 0.006 DBMET02845 0.056 0.006 DBMET02846 | ||
| 0.12 | 0.049 | 0.147 | AMP-activated protein kinase stimulant | 0.147 0.03 DBMET02845 | DBMET02845 | |
| 0.075 | 0.006 | 0.077 | 5-Alpha-reductase 1 inhibitor | 0.077 0.005 DBMET02845 | DBMET02845 | |
| 0.128 | 0.06 | 0.128 | Alkylator | 0.124 0.064 DBMET02846 | ||
| 0.069 | 0.006 | 0.121 | 5-Alpha-reductase 2 inhibitor | 0.121 0.004 DBMET02845 | DBMET02845 | |
| 0.212 | 0.152 | 0.281 | Caspase 3 stimulant | 0.281 0.089 DBMET02846 | DBMET02846 | |
| 0.076 | 0.018 | 0.076 | Heme oxygenase stimulant | 0.072 0.023 DBMET02845 0.072 0.022 DBMET02846 | ||
| 0.141 | 0.083 | 0.141 | Acetylcholine M1 receptor antagonist | |||
| 0.074 | 0.019 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.061 0.028 DBMET02845 | ||
| 0.066 | 0.017 | 0.066 | Estradiol 17 beta-dehydrogenase inhibitor | 0.066 0.017 DBMET02845 0.037 0.034 DBMET02846 | ||
| 0.061 | 0.028 | 0.063 | Pregnane X receptor antagonist | 0.063 0.024 DBMET02845 | DBMET02845 | |
| 0.045 | 0.013 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.037 0.018 DBMET02845 0.029 0.026 DBMET02846 | ||
| 0.228 | 0.199 | 0.273 | Antibacterial | 0.273 0.156 DBMET02845 0.27 0.159 DBMET02846 | DBMET02845 | |
| 0.086 | 0.058 | 0.107 | Transcription factor NF kappa B stimulant | 0.107 0.033 DBMET02845 0.088 0.054 DBMET02846 | DBMET02845 | |
| 0.104 | 0.084 | 0.128 | Microtubule formation inhibitor | 0.128 0.052 DBMET02845 0.099 0.093 DBMET02846 | DBMET02845 | |
| 0.071 | 0.053 | 0.071 | Glycine receptor agonist | |||
| 0.048 | 0.03 | 0.048 | Microtubule stabilization | 0.047 0.032 DBMET02845 0.047 0.032 DBMET02846 | ||
| 0.024 | 0.008 | 0.024 | Progesterone receptor B antagonist | 0.023 0.009 DBMET02845 0.021 0.01 DBMET02846 | ||
| 0.032 | 0.016 | 0.032 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 DBMET02846 | ||
| 0.047 | 0.032 | 0.047 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.037 DBMET02846 | ||
| 0.016 | 0.004 | 0.016 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.016 0.004 DBMET02845 0.016 0.004 DBMET02846 | ||
| 0.074 | 0.067 | 0.074 | Glycine receptor antagonist | |||
| 0.02 | 0.013 | 0.02 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.02 0.013 DBMET02845 | ||
| 0.076 | 0.07 | 0.076 | Antineoplastic alkaloid | 0.076 0.071 DBMET02846 | ||
| 0.015 | 0.015 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 DBMET02845 | DBMET02845 | |
| 0.02 | 0.02 | 0.021 | Vitamin D receptor antagonist | 0.021 0.018 DBMET02845 | DBMET02845 | |
| 0.115 | 0.137 | 0.136 | Adenylate cyclase stimulant | 0.136 0.088 DBMET02845 | DBMET02845 | |
| 0.072 | 0.096 | 0.109 | Monophenol monooxygenase inhibitor | 0.109 0.07 DBMET02845 | DBMET02845 | |
| 0.151 | 0.191 | 0.208 | Peptidyltransferase inhibitor | 0.208 0.089 DBMET02845 | DBMET02845 | |
| 0.031 | 0.095 | 0.093 | HIV-1 integrase (Strand Transfer) inhibitor | 0.093 0.025 DBMET02846 | DBMET02846 | |
| 0.026 | 0.162 | 0.072 | HIV-1 integrase (3'-Processing) inhibitor | 0.072 0.038 DBMET02846 | DBMET02846 | |
| 0.112 | 0.548 | 0.248 | Calcium channel L-type activator | 0.248 0.207 DBMET02845 | DBMET02845 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |